Tianshui Zhongxing completes 2025 stock option grant registration

Tianshui Zhongxing Bio-Technology Co., Ltd. (SZSE:002772) announced the successful completion of the initial grant registration for its 2025 stock option incentive plan. The registration, completed on November 14, 2025, covers 11.50m stock options granted to 17 individuals, with an exercise price of RMB 6.87 per share. The options were initially granted on October 15, 2025.

The incentive plan's options will vest in three tranches over 12, 24, and 36 months, corresponding to 40%, 30%, and 30% of the total options, respectively. Performance targets for vesting include 2025 consolidated operating revenue of at least RMB 2.1bn or a 55% increase in non-recurring net profit compared to 2024. Similar targets are set for 2026 and 2027.

The company estimates the total cost of the initial grant to be RMB 35.9398m, to be amortized over several years, with RMB 5.9027m in 2025, RMB 19.9213m in 2026, RMB 7.5086m in 2027, and RMB 2.6073m in 2028. This plan is expected to boost employee motivation and overall operational efficiency, positively impacting long-term performance.